Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fouladi, M.
Right arrow Articles by Heideman, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fouladi, M.
Right arrow Articles by Heideman, R. L.
Journal of Clinical Oncology, Vol 17, Issue 10 (October), 1999: 3234-3237
© 1999 American Society for Clinical Oncology

Comparison of CSF Cytology and Spinal Magnetic Resonance Imaging in the Detection of Leptomeningeal Disease in Pediatric Medulloblastoma or Primitive Neuroectodermal Tumor

Maryam Fouladi, Amar Gajjar, James M. Boyett, Andrew W. Walter, Stephen J. Thompson, Thomas E. Merchant, Jesse J. Jenkins, James W. Langston, Aiyi Liu, Larry E. Kun, Richard L. Heideman

From the Departments of Hematology-Oncology, Radiation Oncology, Pathology and Laboratory Medicine, Biostatistics and Epidemiology, and Radiology, St Jude Children's Research Hospital; and Departments of Pediatrics, Radiation Oncology, and Radiology, University of Tennessee, College of Medicine, Memphis, TN.

Address reprint requests to Maryam Fouladi, MD, St Jude Children's Research Hospital; Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 N Lauderdale, Memphis, TN 38105; email maryam.fouladi{at}stjude.org

PURPOSE: Leptomeningeal disease (LMD) significantly affects the prognosis and treatment of pediatric patients with medulloblastoma or primitive neuroectodermal tumor (PNET). Examination of CSF for malignant cells, detection of LMD on spinal magnetic resonance imaging (MRI), or both are the methods routinely used to diagnose LMD. A recent study suggested 100% correlation between CSF and MRI findings in children with medulloblastoma. To determine the validity of this hypothesis, we compared the rate of detection of LMD between concurrent lumbar CSF cytology and spinal MRI performed at diagnosis in patients with medulloblastoma or PNET.

PATIENTS AND METHODS: As a part of diagnostic staging, 106 consecutive patients newly diagnosed with medulloblastoma or PNET were evaluated with concurrent lumbar CSF cytology and spinal MRI. CSF cytology was examined for the presence of malignant cells and spinal MRI was reviewed independently for the presence of LMD.

RESULTS: Thirty-four patients (32%) were diagnosed with LMD based on CSF cytology, spinal MRI, or both. There were 21 discordant results. Nine patients (8.5%) with positive MRI had negative CSF cytology. Twelve patients (11.3%) with positive CSF cytology had negative MRIs. The exact 95% upper bounds on the proportion of patients with LMD whose disease would have gone undetected using either CSF cytology or MRI as the only diagnostic modality were calculated at 14.4% and 17.7%, respectively.

CONCLUSION: With the use of either CSF cytology or spinal MRI alone, LMD would be missed in up to 14% to 18% of patients with medulloblastoma or PNET. Thus, both CSF cytology and spinal MRI should routinely be used to diagnose LMD in patients with medulloblastoma or PNET.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
F. Yang, T. E. Van Meter, R. Buettner, M. Hedvat, W. Liang, C. M. Kowolik, N. Mepani, J. Mirosevich, S. Nam, M. Y. Chen, et al.
Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas
Mol. Cancer Ther., November 1, 2008; 7(11): 3519 - 3526.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
V. Oyharcabal-Bourden, C. Kalifa, J.C. Gentet, D. Frappaz, C. Edan, P. Chastagner, E. Sariban, A. Pagnier, A. Babin, F. Pichon, et al.
Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study
J. Clin. Oncol., July 20, 2005; 23(21): 4726 - 4734.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
K. K. Koeller and E. J. Rushing
From the Archives of the AFIP: Medulloblastoma: A Comprehensive Review with Radiologic-Pathologic Correlation
RadioGraphics, November 1, 2003; 23(6): 1613 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. P. Meyers, S. L. Wildenhain, J.-K. Chang, E. C. Bourekas, P. F. Beattie, D. N. Korones, D. Davis, I. F. Pollack, and R. A. Zimmerman
Postoperative Evaluation for Disseminated Medulloblastoma Involving the Spine: Contrast-enhanced MR Findings, CSF Cytologic Analysis, Timing of Disease Occurrence, and Patient Outcomes
AJNR Am. J. Neuroradiol., October 1, 2000; 21(9): 1757 - 1765.
[Abstract] [Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1999 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online